Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aptose Biosciences Inc market cap is $4.31M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aptose Biosciences Inc 52 week high is $1.85 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aptose Biosciences Inc 52 week low is $0.8866 as of November 21, 2026.
Aptose Biosciences Inc stock price today is $1.69.
Aptose Biosciences Inc stock price yesterday was $1.68.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aptose Biosciences Inc's P/E ratio is -0.16.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aptose Biosciences Inc P/B ratio is -0.1244.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aptose Biosciences Inc 50-day moving average is $1.65.